Zygomatic and Pterygoid Implants Market by Length (Upto 30 mm, 31 to 40 mm, 41 to 50 mm, Other Lengths) by Application (Maxillary Sinuses, Severe Atrophy of Maxillary Bone, Other Applications) by End-user (Dental & Orthodontic Clinics, Hospitals) - Growth, Future Prospects & Competitive Analysis, 2015 – 2027

Zygomatic & pterygoid implants are two types of long implants, which are used when the number or quality of the patient's bones is insufficient to anchor the conventional-sized implants. In these cases, harder bones are used (such as those in the cheekbone area) to anchor the implants because they always maintain their stiffness and density. The global zygomatic & pterygoid implants market is expected to cross market value of USD 421.24 million in 2027 from USD 221.69 million in 2020. It is expected to grow at a CAGR of over 8.5% during the forecast period.

Nylon Monofilament Market

Mounting Geriatric Population to Fuel the Demand for Zygomatic Implants      

The increase in the elderly population and the increase in the incidence of dental diseases and injuries are the key driving factors for the severe atrophy of the maxillary segment. Severe maxillary bone atrophy happens due to resorption and pneumatization of the maxillary sinus bone, which is a common disease in the geriatric population. Zygomatic implant is a highly predictable surgery with a high success rate in repairing atrophic jaws, without the need for complex bone augmentation surgery. Additionally, the high adoption rate of new technologies and preferential reimbursement for dental implants have also greatly promoted the growth of the entire regional market.

Higher Cost to Have Adverse Impact on Growth Rate of Zygomatic & Pterygoid Implants

Cost of Zygomatic & Pterygoid Implants vary drastically across the regions. Price band for Zygomatic & Pterygoid Implants begin with as low as USD 15 K and goes as high as USD 40 K. Most of the time, this cost is also inclusive of surgery, appointments and other treatments. Higher cost of Zygomatic & Pterygoid Implants making out of reach from the economically underprivileged people with no health insurance policy. This is turning out to be major factor arresting the growth of Zygomatic & Pterygoid Implants industry.  

Recently, pterygoid and zygomatic implant solutions have become more and more popular among patients because these procedures provide better treatment results, while reducing overall surgical costs, increasing healing and shortening treatment time. Zygomatic and pterygoid bone implantation avoids major surgical fields and flaps, thereby reducing the incidence of treatment.

Impact of COVID 19

COVID-19 has had a huge impact on the global healthcare market. This led the different governments to implement isolation rules and regulations blocking the revenue generation streams of economy. Governments around the world have formulated policies to deal with the many impacts of COVID-19 to avoid supply chain issues, complex raw material costs, and serious financial consequences for employees. This in turn affecting every aspect of life including Zygomatic & Pterygoid Implants industry.  

Europe to Govern the Global Zygomatic & Pterygoid Implants Market

The global zygomatic & pterygoid implants market covers the regions, such as Asia Pacific, Europe, North America, Middle East and Africa, Latin America (LATAM), including all the key economies in these regions. Europe market is projected to account for highest revenue share in the global market, due to the availability of Zygomatic & Pterygoid Implants, access to better healthcare infrastructure, higher spending capacity of citizens, favorable insurance policies, etc. and this dominance is likely to continue over the forecast period. Additionally, presence major manufacturers and deep routed distribution network, high level of health awareness among individuals have remained influential in driving the growth of this industry in the region. Moreover, High cost of Zygomatic & Pterygoid Implants is one of the major issues for the end-users. However, favorable reimbursement policies from different insurance providers is expected to offset this factor. Zygomatic implant procedure is covered under dental insurance plans by major providers. This in turn fueling the demand for Zygomatic & Pterygoid Implants in U.S. and Europe.

31 to 40 MM is Most Commonly Used Length Zygomatic & Pterygoid Implants

Upto 30 mm, 31 to 40 mm, 41 to 50 mm, and other lengths are the lengths in the zygomatic & pterygoid implants market. In 2020, 31 to 40 mm segment is accounted for the largest share over 45% of zygomatic & pterygoid implants Market. 31 to 40 MM is most commonly used length of zygomatic & pterygoid implants. Large chunk of zygomatic & pterygoid implants users fall in the range of 31 to 40 MM around the world and hence this segment is paving the way for the growth of this industry.

Zygomatic & Pterygoid Implants Growth is Led by Atrophy of Maxillary Bone Application

Maxillary sinuses, severe atrophy of maxillary bone, etc. are the key applications of zygomatic & pterygoid implants market. Severe atrophy of maxillary bone segment accounted for the largest share over 45% in 2020 of the zygomatic & pterygoid implants market in 2020. Zygomatic & pterygoid implants industry participants are mainly focusing on research & development.

Stakeholders in the zygomatic and pterygoid implants market are focused on long-term stability and high level of patient satisfaction. Advancement in 3D reconstruction technology have improved the placement of zygomatic implants and promoted the prospects of the zygomatic and pterygoid implants market. Progress in surgical implant guidance have been driving the growth avenues. Favorable reimbursement policies and technological advancements are also stimulating growth of this industry.

Frequently asked questions about global industry

Upto 30 mm, 31 to 40 mm, 41 to 50 mm, etc. are major lengths of zygomatic & pterygoid implants, out of which 31 to 40mm segment dominated the global market with just under two third share in the global market. Dominance of 31 to 40mm segment can be attributed to the abundance of its availability across the world.

Some of the major players operating in zygomatic & pterygoid implants industry include, Nobel Biocare, IDC Implant & Dental Company, Straumann Holding AG, Noris Medical, S.I.N. Implant System, Southern Implants (Pty) Ltd., and Bioline Dental Implants. The top three players collectively accounted for over 35% share in the global market.

Severe atrophy of maxillary bone is the largest application of zygomatic & pterygoid implants which held over 45% share in the global consumption in 2020

Europe hold the largest share owing to large demand of zygomatic & pterygoid implants due to increase in the elderly population, coupled with increased incidence of dental diseases and injuries.

Growing rate of complications linked to implant-associated infections is the major challenge for the growth of zygomatic & pterygoid implants industry.

Choose License Type
Trusted By
Published Date:  Oct 2021
Category:  Medical Devices
Report ID:   59650
Report Format:   PDF
Pages:   175
Rating:    4.2 (49)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
24/7 Research Support